References
- Shore D, Matthews S, Cott J, Jeffrey A: Clinical implications of clozapine discontinuation: report of an NIMH workshop. Schizo Bull 1995; 21:333–338
- Taylor MA: Catatonia: A review of a behavioural neurologic syndrome. Neuropsychiatr, Neuropsychol Behav Neurol 1990; 3:48–72
- Stauder KH: Die todliche katatonie. Arch Psychiatr Nervenkr. 1934; 102:614–634
- Philbrick KL, Rummans TA: Malignant catatonia. J Neurop-sychiatry Clin Neurosci 1994; 6:1–13
- Lohr JB, Wisniewsld AA: Movement Disorders: A Neuropsy-chiatric approach. New York: Guilford, 1987
- Bush G, Fink M, Dowling F, Francis A: Catatonia. I. Rating scale and standardised examination. Acta Psychiatr Scand 1996; 93:137–143
- Morrison JR: Catatonia: Retarded and excited types. Arch Gen Psychiatry 1973; 28:39–41
- De Leon J, Stanilla JIC, White AO, Simpson GM: Anticholin-ergics to treat clozapine withdrawal. J Clin Psychiatry 1994; 55:3–4
- Verghese C, De Leon J, Nair C, Simpson GM: Clozapine withdrawal effects and receptor profiles of typical and atypical neuroleptics. Biol Psychiatry 1996; 39:135–138
- Dilsaver SC, Gardos G: Antidepressant withdrawal symptoms treated with anticholinergic agents. Am J Psychiatry 1983; 140:249–251
- Gardos G, Cole JO, Tarsy D: Withdrawal syndrome associated with antipsychotic drugs. Am J Psychiatry 1978; 135:1321–1324
- Parsa MA, Ramirez LF, Meltzer HY: Prolonged psychotic re-lapse after abrupt clozapine withdrawal. J Clin Psychopharma-col 1993; 13:154–155
- Alphs LD, Lee HS: Comparison of withdrawal of typical and atypical antipsychotic drugs: A case study. J Clin Psychiatry 1991; 52:346–348
- Ekblom B, Erikson K, Lindstrom LH: Supersensitivity psycho-sis in schizophrenic patients after sudden clozapine with-drawal. Psychopharmacology 1984; 83:293–294
- Luchins DJ, Freed WJ, Wyatt RJ: The role of cholinergic su-persensitivity in the medical symptoms associated with with-drawal of anticholinergic drugs. Am J Psychiatry 1980; 137:1395–1398
- Albucher RC, De Quardo J, Tandon R: Treatment of catato-nia with an anticholinergic agent. Biol Psychiatry 1991; 29:513–514
- Menza MA, Harris D: Benzodiazepines and catatonia: An overview. Biol Psychiatry 1989; 26:842–846
- Mann SC, Caroff SN, Bleier HR, Welz WKR, Kling MA, Hayashida M: Lethal catatonia. Am J Psychiatry 1986; 143:1374–1381
- Kurtan R, Hamill R, Shoulsm I: Neuroleptic malignant syn-drome. Clin Neuropharmacol 1984; 7:109–120
- Castillo E, Rubin RT, Holsboer-Trachsler E: Clinical differ-entiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry 1989; 146:324–328
- Lee WYJ: Catatonia: The tension insanity. Br J Psychiatry 1993; 163:696 (published erratum appears in Brit J Psychiatry 1994; 164: 1341)
- Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF: Catatonic syndrome in a general psychiatric population: Fre- quency, clinical presentation, and response to lorazepam. J Clinical Psychiatry 1990; 51:357–362
- Lee JWY: Catatonia and ECT. Aust NZ J Psychiatry 1994; 28:690–691
- Hafner H, Kasper S: Akute lebensbedrohliche Katatonie: Epedemiologische und Klinische Befunde. Nervenzart 1982; 53:385–394
- Ichikawa J, Meltzer HY: Differential effects of repeated treat-ment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. J Pharmacol Exp Ther 1991; 256:348–357
- Fricchione GL: Neuroleptic catatonia and its relationship to psychogenic catatonia. Biol Psychiatry 1985; 20:304–313